|
Index of reports
> Cases with Febrile Neutropenia (65)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 65 Next >>
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Prednisolone side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Prednisolone side effects in male
Reported by a physician from United Kingdom on 2012-08-16
Patient: male, weighing 62.4 kg (137.3 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-05-31
Bendamustine Hydrochloride
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-05-31
Prednisolone
Dosage: 20mg as required
Administration route: Oral
Start date: 2012-05-31
Other drugs received by patient: Metoclopramide; Chlorpheniramine Maleate; Allopurinol; Acyclovir; Acetaminophen; Neupogen
Possible Prednisolone side effects in female
Reported by a physician from India on 2012-08-15
Patient: female
Reactions: Pancytopenia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: restarted
Indication: Renal Transplant
Start date: 2012-07-31
Cyclosporine
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-26
Prednisolone
Indication: Renal Transplant
Uloric
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Pantoprazole Sodium; Folvite
Possible Prednisolone side effects in female
Reported by a physician from Germany on 2012-07-24
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1493 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin Hydrochloride
Dosage: 100 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Pegfilgrastim
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Prednisolone
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Rituximab
Dosage: 742.5 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Vincristine
Dosage: 3.54 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Ramipril; Trimethoprim; Levothyroxine / 00068002 /; Simvastatin; Enoxaparin Sodium; Acetylsalicylic Acid SRT; Acyclovir; Pantoprazole; Nebivolol; Torsemide; Tiotropium Bromide
Possible Prednisolone side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-11
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Start date: 2011-01-13
Doxorubicin HCL
Indication: Lymphoma
Start date: 2011-01-13
Mabthera
Indication: Lymphoma
Start date: 2011-01-13
Prednisolone
Dosage: 40 mg/m2;
Administration route: Oral
Indication: Lymphoma
Start date: 2011-01-13
End date: 2011-01-17
Vincristine
Indication: Lymphoma
Start date: 2011-01-13
Other drugs received by patient: Nexium
Possible Prednisolone side effects in female
Reported by a physician from Malaysia on 2012-07-11
Patient: female, weighing 66.8 kg (147.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Gp2013
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Blinded Mabthera
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Blinded NO Treatment Received
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Cyclophosphamide
Dosage: 125 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Prednisolone
Dosage: 100 mg, qd
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Vincristine
Dosage: 2 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Other drugs received by patient: Allopurinol
Possible Prednisolone side effects in 5 year old male
Reported by a physician from Japan on 2012-07-10
Patient: 5 year old male
Reactions: Stomatitis, Febrile Neutropenia, Gastritis Haemorrhagic
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 250 mg/m2, unk
Cyclophosphamide
Dosage: 150 mg/m2, unk
Indication: Burkitt's Leukaemia
Dexamethasone Sodium Phosphate
Dosage: 10 mg/m2, unk
Indication: Burkitt's Leukaemia
Methotrexate Sodium
Dosage: 5g/m2
Indication: Burkitt's Leukaemia
Omnipaque 140
Dosage: unk
Pirarubicin
Dosage: 30 mg/m2, unk
Indication: Burkitt's Leukaemia
Prednisolone
Dosage: 60 mg/m2, unk
Prednisolone
Dosage: 30 mg/m2, unk
Indication: Burkitt's Leukaemia
Vincristine Sulfate
Dosage: 1.5 mg/m2, unk
Vincristine Sulfate
Dosage: 1 mg/m2, unk
Indication: Burkitt's Leukaemia
Other drugs received by patient: Manitol
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2
Cyclophosphamide
Dosage: 250 mg/m2, bid for six doses
Indication: non-Hodgkin's Lymphoma
Cytarabine
Dosage: 100 mg/m2, daily x 5 days
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 30 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 60 mg/m2, single
Hydrocortisone Acetate
Dosage: given with methotrexate
Indication: non-Hodgkin's Lymphoma
Hydrocortisone Acetate
Dosage: given with cytarabine
Methotrexate
Dosage: 3000 mg/m2, single
Methotrexate
Dosage: given with hydrocortisone twice x 2
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1500 mg/m2, single
Prednisolone
Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
Indication: non-Hodgkin's Lymphoma
Prednisolone
Dosage: 60 mg/m2, daily for 7 days
Rituximab
Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg/m2, single
Vincristine
Dosage: 1 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Possible Prednisolone side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Prednisolone
Dosage: 500 mg, qd
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir
Possible Prednisolone side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Possible Prednisolone side effects in
Reported by a physician from France on 2012-06-27
Patient:
Reactions: Febrile Neutropenia, Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Dosage: on days 1-5, every 21 days for 6 cycles
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26
Patient:
Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: given on day 1 of each cycle
Indication: B-Cell Lymphoma
Mabthera
Dosage: on day 1 of every cycle
Indication: B-Cell Lymphoma
Prednisolone
Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
Administration route: Oral
Indication: B-Cell Lymphoma
Vincristine
Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Methotrexate
Dosage: 3000 mg/m2; administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Possible Prednisolone side effects in 68 year old male
Reported by a physician from United Kingdom on 2012-06-21
Patient: 68 year old male, weighing 131.0 kg (288.2 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-05-17
End date: 2012-05-17
Prednisolone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-05-17
End date: 2012-05-17
Other drugs received by patient: Adcal-D3; Naproxen; Morphine Sulfate; Lansoprazole; Acetaminophen and Codeine Phosphate; Budesonide / Formoterol
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Prednisolone side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 62 year old male
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 300 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: 100 mg/m2, for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: unknown
Doxorubicin HCL
Dosage: 30 mg/m2, unk
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Dosage: unknwon
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Dosage: 30000 mg/m2, unk
Methotrexate
Prednisolone
Dosage: 60 mg/m2, for 5 days, then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, for 5 days then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, per day for 7 days
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: every 2-4 weeks for 5 total doses with cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: cumulative dose of 1875 mg/m2
Vincristine
Dosage: 2 mg/m2, unk
Vincristine
Dosage: 1 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: 1 mg/m2, unk
Possible Prednisolone side effects in
Reported by a individual with unspecified qualification from Austria on 2012-06-18
Patient:
Reactions: Cardiac Failure, Febrile Neutropenia, Cardiotoxicity, Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Vincristine Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-14
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine Sulfate
Start date: 2012-04-26
Possible Prednisolone side effects in 64 year old female
Reported by a physician from Japan on 2012-06-12
Patient: 64 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Gastrointestinal Haemorrhage, Gastritis Erosive, Constipation, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Ileus, Oedema, Gastrooesophageal Reflux Disease, Renal Failure Acute, Decreased Appetite, White Blood Cell Count Decreased, Vomiting, Stomatitis, Nausea, Anaemia, Febrile Neutropenia, Diarrhoea, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Marzulene-S
Dosage: 3 packs
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-19
End date: 2009-08-18
Omeprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-19
End date: 2009-05-25
Oncovin
Dosage: 20may09-20may09 27may09-27may09 03jun09-03jun09 10jun09-10jun09 14aug09-14aug09
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-05-20
End date: 2009-08-14
Prednisolone
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-05-27
End date: 2009-06-16
Sprycel
Dosage: therapy interrupted on 04sep09,restarted on 24sep09.
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-05-27
End date: 2009-10-09
Other drugs received by patient: Granisetron HCL; Doxorubicin HCL; Leucovorin Calcium; Uralyt; Bactrim; Potassium Citrate; Cyclophosphamide; Sulbactam Sodium; Acetazolamide; Gasmotin; Sodium Citrate; Diart; Methylprednisolone Sodium Succinate; Neuquinon; Cytarabine; Oren-Gedoku-TO; Trimethoprim; Dexamethasone Sodium Phosphate; Ampicillin Sodium; Mosapride Citrate; Granisetron HCL; Methotrexate; Amikacin Sulfate; Carbazochrome Sodium Sulfonate; Amino Acid INJ; Miya-BM; Aldactone; Maxipime
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-06-11
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Rulid; Electrolytes NOS W / Macrogol 3350; Acyclovir; Dipyrone TAB; Metoclopramide; Pantoprazole; MST / 00036302 /; Novalgin / 00169801 /; Paspertin / 00041902 /; Acyclovir
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Prednisolone side effects in 77 year old male
Reported by a physician from Denmark on 2012-05-29
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-05-22
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acyclovir
Dosage: 400 mg, unk
Administration route: Oral
Cytoxan
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Acyclovir; Paspertin / 00041902 /; Metoclopramide; Rulid; Pantoprazole; Electrolytes NOS W / Macrogol 3350; Dipyrone TAB; MST / 00036302 /; Novalgin / 00169801 /
Possible Prednisolone side effects in male
Reported by a physician from Russian Federation on 2012-05-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Reactions: Febrile Neutropenia, Infectious Peritonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Gp2013
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Blinded Mabthera
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Blinded NO Treatment Received
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Cyclophosphamide
Dosage: 995.6 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Prednisolone
Dosage: 100 mg/d
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Vincristine
Dosage: 2 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-01-31
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-05-10
Patient: male
Reactions: Febrile Neutropenia, Neutropenia, Skin Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Rulid; Metoclopramide; Pantoprazole; Electrolytes NOS W / Macrogol 3350; Novalgin / 00169801 /; MST / 00036302 /; Dipyrone TAB; Acyclovir; Paspertin / 00041902 /
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-05-02
Patient: male
Reactions: Febrile Neutropenia, Skin Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
Other drugs received by patient: MST / 00036302 /; Acyclovir; Novalgin / 00169801 /; Pantozol / 01263204 /; Electrolytes NOS W / Macrogol 3350; Paspertin / 00041902 /; Rulid
Page 1 Next >>
|
